Skip to main content
Advertisement
  • Loading metrics

Reciprocal interaction between IK1 and If in biological pacemakers: A simulation study

  • Yacong Li,

    Roles Data curation, Formal analysis, Investigation, Methodology, Software, Validation, Visualization, Writing – original draft

    Affiliation School of Computer Science and Technology, Harbin Institute of Technology, Harbin, China

  • Kuanquan Wang ,

    Roles Project administration, Resources, Supervision

    [email protected] (KW); [email protected] (HZ)

    Affiliation School of Computer Science and Technology, Harbin Institute of Technology, Harbin, China

  • Qince Li,

    Roles Methodology

    Affiliations School of Computer Science and Technology, Harbin Institute of Technology, Harbin, China, Peng Cheng Laboratory, Shenzhen, China

  • Jules C. Hancox,

    Roles Formal analysis, Writing – review & editing

    Affiliations School of Physiology, Pharmacology and Neuroscience, Medical Sciences Building, University Walk, Bristol, United Kingdom, Biological Physics Group, School of Physics and Astronomy, The University of Manchester, Manchester, United Kingdom

  • Henggui Zhang

    Roles Conceptualization, Formal analysis, Funding acquisition, Methodology, Project administration, Resources, Software, Supervision, Visualization, Writing – review & editing

    [email protected] (KW); [email protected] (HZ)

    Affiliations Peng Cheng Laboratory, Shenzhen, China, Biological Physics Group, School of Physics and Astronomy, The University of Manchester, Manchester, United Kingdom, Key Laboratory of Medical Electrophysiology of Ministry of Education and Medical Electrophysiological Key Laboratory of Sichuan Province, Institute of Cardiovascular Research, Southwest Medical University, Luzhou, China

Abstract

Pacemaking dysfunction (PD) may result in heart rhythm disorders, syncope or even death. Current treatment of PD using implanted electronic pacemakers has some limitations, such as finite battery life and the risk of repeated surgery. As such, the biological pacemaker has been proposed as a potential alternative to the electronic pacemaker for PD treatment. Experimentally and computationally, it has been shown that bio-engineered pacemaker cells can be generated from non-rhythmic ventricular myocytes (VMs) by knocking out genes related to the inward rectifier potassium channel current (IK1) or by overexpressing hyperpolarization-activated cyclic nucleotide gated channel genes responsible for the “funny” current (If). However, it is unclear if a bio-engineered pacemaker based on the modification of IK1- and If-related channels simultaneously would enhance the ability and stability of bio-engineered pacemaking action potentials. In this study, the possible mechanism(s) responsible for VMs to generate spontaneous pacemaking activity by regulating IK1 and If density were investigated by a computational approach. Our results showed that there was a reciprocal interaction between IK1 and If in ventricular pacemaker model. The effect of IK1 depression on generating ventricular pacemaker was mono-phasic while that of If augmentation was bi-phasic. A moderate increase of If promoted pacemaking activity but excessive increase of If resulted in a slowdown in the pacemaking rate and even an unstable pacemaking state. The dedicated interplay between IK1 and If in generating stable pacemaking and dysrhythmias was evaluated. Finally, a theoretical analysis in the IK1/If parameter space for generating pacemaking action potentials in different states was provided. In conclusion, to the best of our knowledge, this study provides a wide theoretical insight into understandings for generating stable and robust pacemaker cells from non-pacemaking VMs by the interplay of IK1 and If, which may be helpful in designing engineered biological pacemakers for application purposes.

Author summary

Pacemaking dysfunction has become one of the most severe cardiac diseases, which may result in arrhythmia and even death. The treatment of pacemaking dysfunction by electronic pacemakers has saved millions of people in the past fifty years. However not every patient can benefit from these because of possible limitations, such as surgical implication and lack of response to the autonomic stimulus. The development of biological pacemaker based on gene engineering technology provides a promising alternative to the electronic pacemaker by manipulating the gene expression of cardiac cells. However, it is still unclear how a stable and robust biological pacemaker can be generated in this way. The present study aims to elucidate possible mechanisms responsible for a bio-engineered pacemaker using a computational electrophysiological model by modifying ionic channel properties of IK1 and incorporating If in a human ventricular cell model. Simulation results indicated that the reciprocal interaction between IK1 and If determined the stability and ability of biological pacemaker. This study provides new insight into the understanding of the initiation of pacemaking behaviours in non-rhythmic cardiac myocytes, providing a theoretical basis for experimental design of biological pacemakers.

Introduction

Currently, electronic pacemaker implantation is the only non-pharmacological therapy for some patients with pacemaking dysfunction. But electronic pacemakers have some possible limitations [1]. Implantation of a pacemaker device may have complications for patients, especially for aged ones because of their infirm health [2]. Pediatric patients can receive electronic pacemakers; however, the device has to be replaced as they grow, and repeated surgeries are needed [3]. Electronic devices can be subject to electromagnetic interference [4], which causes inconvenience to the patients. A further issue is that classical electronic pacemakers are insensitive not only to hormone stimulation [5] but also to autonomic emotion responsiveness [4], although there are some attempts to make them respond to autonomic nervous control [6]. In addition, the long-term use of electronic pacemakers has been reported to increase the risk of heart failure [7]. Appropriately designed biological pacemakers (bio-pacemakers) have the potential to overcome some of the limitations of electrical device use [8], such as the lack of pacing flexibility. Also, engineered bio-pacemakers could potentially involve only minor surgical trauma for implantation as well as facilitating chronotropic responses [9]. In previous experimental studies, it has been shown that a bio-pacemaker can be engineered via adenoviral gene transduction [1012] or lentiviral vector [13,14] techniques, by which non-pacemaking cardiac myocytes (CMs) can be transformed to the rhythmic pacemaker-like cells.

The native cardiac primary pacemaker, sinoatrial node (SAN), is a special region comprised of cells with distinct electrophysiological properties to those of cells in the working myocardium. Such intrinsic and special electrophysiological properties of SAN cells are mainly manifested by their small if not absent inward rectifier potassium channel current (IK1) [15], but a large “funny” current (If) [16] that is almost absent in atrial and ventricular cells. IK1 helps to hyperpolarize cell membrane potential and contributes to maintaining a stable negative resting potential in ventricular myocytes (VMs). But in the SAN, absence of IK1 makes a more positive maximum diastolic potential (MDP) than the resting potential in VMs, which helps its depolarization. If plays an important role in phase 4 depolarization of SAN action potentials, thus influences the pacemaking rate in the SAN [17]. In addition to the absence of IK1 and presence of If, T-type Ca2+ channel current (ICaT) [18] and sustained inward current (Ist) [19] also contribute to spontaneous pacemaking activity in SAN cells. Similar to If, ICaT plays a role in the depolarization in the SAN but is usually undetectable in VMs. Such unique electrophysiological properties of SAN cells formed a theoretical basis to engineer non-pacemaking CMs into spontaneous pacemaker cells. These non-pacemaker cells include native CMs, such as ventricular [11,2022], atrial [23] or bundle branch myocytes [24]. They can also be stem cells, such as embryonic stem cells [2527], bone marrow stem cells [13,28,29], adipose-derived stem cells [3032], or induced pluripotent stem cell [14,33,34].

With gene therapy, these non-rhythmic cells have been manipulated to provoke automaticity. In previous studies, knocking down the Kir2.1 gene to reduce the expression of IK1 promoted spontaneous rhythms in newborn murine VMs [20]; by reprogramming the Kir2.1 gene in guinea-pigs, VMs also produced pacemaker activity when IK1 was suppressed [11,21]. As If plays an important role in the native SAN cell pacemaking, a parallel gene therapy manipulation to create engineered bio-pacemaker has been carried out by expressing the HCN gene family in non-rhythmic CMs [35]. It has been shown that expressing HCN2 produced escape beats in canine CMs [23,24] and initiated spontaneous beats in neonatal rat VMs [22]. HCN expression in stem cells-induced-CMs also enhanced their pacemaking rate [13,28,29,36,37]. Overexpressing HCN4 can also induce spontaneous pacemaking activity in mouse embryonic stem cells [38]. However, acute HCN gene expression might have a side effect on the normal cardiac pacemaking activity [3941]. The overexpression of the HCN gene in non-rhythmic CMs can cause ectopic pacemaker automaticity and even arrhythmicity [42].

It has been suggested that a combined manipulation of IK1 and If may be a better alternative for creating a bio-pacemaker [43]. The expression of the transcriptional regulator TBX18, which influenced both If and IK1 expression, generated appropriate automatic responses in non-pacemaking CMs [10,32,44]. In addition, reprogramming TBX18 in porcine VMs did not show the increase of arrhythmia risk [12], indicating the probable superiority of manipulating IK1 and If jointly for generating a bio-pacemaker. Furthermore, an experimental study showed that in HEK293 cells with expression of the Kir2.1 and the HCN genes, not only If but also moderate IK1 was necessary to induce spontaneous rhythmic oscillations [45].

Computational modelling offers a means to investigate different approaches to generating stable pacemaking activity. Based on the cardiac cell model, bifurcation analysis was widely used to explore the effect of changes on some individual ion channel current on the pacemaking activities, such as the role of down-regulating IK1 in the pacemaking initiation in VMs [4648] and the role of If in the pacemaking activity in SAN cells [49]. The interplay between multiple ion channel currents in the pacemaking initiation was also investigated in VMs [50] or SAN [51] models, with focus on their roles in sustaining the spontaneous oscillation. Up to now, the dynamic interplay between IK1 and If on modulating the stability of bio-pacemaker action potentials (APs) has not yet been comprehensively investigated in biophysically detailed cardiac single-cell models.

Considering the availability of experimental data on transformation of VMs into rhythmic cells [11,2022] and the cardiac dysfunctions arising from atrioventricular heart-block, we chose the VM cell model for investigating bio-pacemaking activity. In this study, we constructed a bio-pacemaker model based on a human VMs model [52] by manipulating IK1 and incorporating If [53] into the model. This study aimed to investigate (i) possible mechanism(s) underlying the pacemaking activity of the VMs in the IK1/If parameter space; and (ii) the reciprocal interaction of reduced IK1 and increased If in generating stable pacemaking APs. In addition, possible factors responsible for impaired pacemaking activity due to the inappropriate ratio between IK1 and If were also investigated. Moreover, theoretical analysis of the role of ICaT in IK1/If pacemaker model was investigated. This study provides insight into generating stable and robust engineered bio-pacemaker.

Methods

Single bio-pacemaker cell model

Previous experimental studies [10,11,2022] implemented the suppression of Kir2.1, the incorporation of HCN channels and the expression of TBX18 to induce pacemaking in VMs. In this study, we used a human VMs model built by Ten Tusscher et al. in 2006 (TP06 model) [52] as the basal model to investigate possible pacemaking mechanisms in VM-transformed pacemaking cells. In brief, the basal VM cell model can be described by the following ordinary differential equation: (1) where V is the voltage across cell membrane surfaces, t is time, Iion is the sum of all transmembrane ionic currents, and Cm cell capacitance.

The Iion in the original ventricular model is described by the following equation: (2) where INa is fast sodium channel current, IK1 is inward rectifier potassium channel current, Ito is transient outward current, IKr is rapid delayed rectifier potassium channel current, IKs is slow delayed rectifier potassium channel current, ICaL is L-type calcium current, INaCa is Na+/Ca2+ exchange current, INaK is Na+/K+ pump current, IpCa and IpK are plateau Ca2+ and K+ currents, and IbCa and IbNa are background Ca2+ and Na+ currents. The formulations and their parameters for the ionic channels of human VM cells were listed in [52,54].

To mimic the reduction of Kir2.1 expression [11,20,21] or the suppression of IK1 by expressing TBX18 [10], in simulations IK1 was decreased by modulating its macroscopic channel conductance (GK1). To mimic the incorporation of If in VMs experimentally [22], we modified the basal model of Eq 2 by incorporating human SAN If formulation [53]. In simulations, If was modulated by changing its channel conductance (Gf).

As a result, the Iion for the bio-pacemaker model can be described as: (3) where IK1 could be expressed by (4) where GK1 is the conductance of IK1, xk1∞ is a time-independent inward rectification factor, Ko is extracellular K+ concentration and EK is the equilibrium potentials of K+. SK1 is a scaling factor used to simulate the change of IK1 expression level.

The If channel is permeable to Na+ and K+ ions [53]. As a result, If could be described by two components: (5) (6) (7) where Gf,Na and Gf,K are maximal If,Na and If,K channel conductance, y is a time-independent inward rectification factor that is a function of voltage, ENa, EK are equilibrium potentials of Na+ and K+ channels respectively, and Sf is a scaling factor used to simulate the change of If expression level.

Formulations of other channel currents for the VM cell model are the same as those in the original model in [52]. The bio-pacemaker cell model can be found in S1 Code.

ICaT was incorporated into the IK1/If-induced bio-pacemaker cell model to investigate its role in generating pacemaking action potentials. Its formulations can be found in [50]. As a result, the Iion is described as: (8)

Evaluating criterion of the pacemaking stability and ability

To analyse the effect of IK1 and If on pacemaking activity, we simulated the membrane potential under different current densities of IK1 and If, with IK1 being reduced systematically by from between 60–100% (i.e., IK1 density at -80 mV changed from 0.396 to 0 pA/pF while the IK1 density in the original basal model is 0.99 pA/pF at -80 mV in I-V curve). The representative I-V relation curve under different inhibition of IK1 is shown in S1A Fig. If density was increased by from 0 to 10 folds with a basal value of -0.63 pA/pF at -80 mV in I-V curve (i.e., If density changed from 0 to -6.3 pA/pF at -80 mV). The representative I-V relation curve under different incorporation of If is shown in S1B Fig.

Two characteristics were used to quantify the state of membrane potentials generated by the ventricular pacemaker model: the continuity and validity of spontaneous APs. The continuity was used to quantify whether or not the automaticity of membrane potential could sustain with time; whilst the validity was used to characterize whether every automatic wave was biologically-valid or not. As such, we defined the following:

W: a valid wave. An action potential whose wave trough was less than -20 mV and wave crest was more than 20 mV could be considered as a valid wave.

αW, α<1: an incomplete wave.

R: a resting period lasting 1000 ms.

Wn: the concatenation of n W’s.

(W R): the concatenation of W and R.

As such, the pacemaking behaviour of the IK1/If pacemaker model can be categorized as FIVE states whose definitions were as followings:

None pacemaking behaviour during the entire simulation period could be described as State-1: (9)

Transient spontaneous pacemaking behaviour could be described as State-2: (10)

Bursting pacemaking behaviour could be described as State-3: (11)

Persistent pacemaking activity with periodically incomplete depolarization could be described as State-4: (12)

Stable pacemaking activity could be described as State-5: (13)

With regard to the pacemaking ability, when the pacemaking behaviour was stable, the cycle length (CL) under varied IK1 and If was calculated. The CL was defined as the averaged wavelength of pacemaking activity over a period of simulation of more than 400 s, ensuring the accuracy of the computed CL. As the basal model was for VMs, a long simulation period was necessitated to achieve a completely stable pacemaking status and minimize the effect of the transition period.

Characteristics of pacemaking during diastolic interval

The length of the diastolic interval (DI) is an important measure to characterize the pacemaking ability. In this study, we defined that DI as the time interval between the time of MDP (S2A Fig, t1) and the time when the membrane potential reaches at -55 mV (i.e., around the activation potential of ICaL) (S2A Fig, t2). The diastolic upstroke velocity during DI was defined as the change rate of the membrane potential, taking the following formulation: (14)

The unit of diastolic upstroke velocity was V/s.

We evaluated the contributions of all of the inward currents to membrane potential during DI and found that the main inward currents which helped to depolarize membrane potential during DI are INa, INaCa and If. Their contribution can be described by an average integral during DI: (15)

Similarly, the main outward currents which held membrane potential at diastolic potential during DI are IK1, INaK, IKr and IKs, the integral of which can be described as: (16)

Results

Dynamic analysis in IK1/If parameter space

Dynamic pacemaker AP behaviour was dependent on the balance of IK1 and If interactions. Simulations were conducted in the IK1/If parameter space to characterize this dependence. Results are shown in Fig 1. With differing combinations of IK1 and If density, five different regions for distinctive pacemaking dynamics could be discerned, including stable pacemaking activity (blue area, State-5 defined by Eq 13), intermittence of failed depolarization (yellow area, State-4 defined by Eq 12), bursting pacemaking behaviour (orange area, State-3 defined by Eq 11), transient pacemaking activity (green area, State-2 defined by Eq 10), and no automaticity (grey area, State-1 defined by Eq 9). In each category, representative membrane potentials are illustrated at the bottom panel of Fig 1.

thumbnail
Fig 1. Dynamic behaviours of pacemaking action potentials in IK1/If parameter space.

Blue: stable pacemaking activity (State-5); Yellow: persistent pacemaking activity with periodic incomplete depolarization (State-4). Orange: bursting pacemaking behaviour (State-3). Green: transient spontaneous pacemaking behaviour (State-2). Gray: no spontaneous pacemaking behaviour (State-1). In each category, the typical pacemaking action potentials are illustrated at the bottom panel.

https://doi.org/10.1371/journal.pcbi.1008177.g001

With a fixed If density, alterations to IK1 could produce different types of pacemaking activities, and this also applied when IK1 was fixed whilst If was changed. When If density was fixed at a density between -0.63 and -2.52 pA/pF, with a 60–80% block of IK1 (i.e., IK1 density at -80 mV was in the range of 0.198–0.396 pA/pF), pacemaking activity was generated but with self-termination (Fig 1, green area). Then, a further reduction in IK1 or a slight increase in If induced bursting pacemaking behaviour, as shown by the orange area in Fig 1, which was between the boundaries marking the persistent automaticity and transient pacemaking activity regions. A further increase in If or suppression in IK1 could produce persistent automaticity (Fig 1, yellow and blue area). But when IK1 was greater than about 0.248 pA/pF, incomplete depolarization appeared periodically (Fig 1, yellow area). Finally, a stable and spontaneous pacemaking activity could be generated when IK1 was decreased to less than 0.248 pA/pF at -80 mV with If included (Fig 1, blue area).

To illustrate possible reasons responsible for the effect of each changed ion current density on modulating pacemaking states, we chose four typical cases to analyze the corresponding pacemaking mechanisms in different pacemaking states in the IK1/If parameter space. Cases are listed in Table 1.

Initiation of transient spontaneous depolarization

In the basal VM cell model with the suppression of IK1 by 70% (the density of IK1 at -80 mV was 0.297 pA/pF), incorporation of If (with a current density of -0.63 pA/pF) was unable to depolarize the membrane potential and lead to spontaneous pacemaking activity because the excessive outward current of IK1 counteracted the inward depolarizing current. This state can be described by State-1 as shown in Eq 9. When the density of If was increased to -1.89 pA/pF, spontaneous depolarization was provoked at the beginning of the transition period, however, the automaticity self-terminated after 163 s (Fig 2A), showing a State-2 behaviour as described in Eq 10.

thumbnail
Fig 2. Transient spontaneous pacemaking behaviour.

(A-F) Membrane potential (V), intracellular Na+ concentration ([Na+]i), intracellular Ca2+ concentration ([Ca2+]i), fast sodium current (INa), Na+/K+ pumping current (INaK) and L-type calcium channel current (ICaL) with the current densities of (IK1, If) at (0.297 pA/pF, -1.89 pA/pF) (‘CASE 1’) during the entire simulating period of 800 s. (G) Expanded plots of (A-F) for the time course of pacemaking self-termination (160–164 s). H: Maximum diastolic potential of spontaneous pacemaking behaviour of (A).

https://doi.org/10.1371/journal.pcbi.1008177.g002

We analysed possible ion channel mechanisms responsible for unstable and self-terminating pacemaking APs with the current densities of (IK1, If) at (0.297pA/pF, -1.89 pA/pF) (defined as ‘CASE 1’). Results in Fig 2 showed that during the time course of the spontaneous pacemaking, there were changes of intracellular ionic concentrations and the MDP. There was an accumulation of the intracellular Ca2+ concentration ([Ca2+]i, Fig 2C) during the time course of spontaneous pacemaking APs. Such an accumulation of [Ca2+]i was because the automaticity in VMs shortened the DI between two successive APs, leaving insufficient time for Ca2+ in the cytoplasm to be extruded to restore to its initial value after each cycle of excitation. This consequentially led to overload in [Ca2+]i, which suppressed the extent of the activation degree of the L-type calcium current (ICaL, Fig 2F), especially during the phase 0 of the pacemaking action potential. Furthermore, the overloaded [Ca2+]i increased the INaCa (S3A Fig) gradually with time, resulting in an elevated MDP (Fig 2H) that inhibited the activation degree of the fast sodium channel current (INa, Fig 2D). Through the Na+ permeability of If, extra Na+ flowed into the cytoplasm [53] during each of the APs. The increase of INaCa also accelerated the accumulation of the intracellular Na+ concentration ([Na+]i) to increase from 7.67 to 11.8 mM (Fig 2B). The increased [Na+]i augmented the feedback mechanism of Na+/K+ pumping activity, by which the Na+/K+ pump current (INaK) increased gradually with time (Fig 2E). All of these factors worked together, inhibiting the membrane potential to reach the take-off potential, leading to self-terminated automaticity at 163 s (Fig 2G).

It was also possible to generate automaticity in the model by fixing the current density of If at a low value, but with a further reduction in IK1 density. S4 Fig shows the results when If was held at -0.63 pA/pF and the current density of IK1 was reduced to 0.178 pA/pF. In this case, pacemaking activity appeared in the model, but the automaticity was unstable and self-terminated due to similar mechanisms as shown in Fig 2 for the increased-If situation.

Bursting pacemaking behaviour

Fig 3 shows the intermittent bursting behaviour, which is generated with a different combination of IK1 and If current densities in the model. In the figure, the current densities of (IK1, If) were at (0.297 pA/pF, -2.52 pA/pF) (defined as ‘CASE 2’). Such kind of pacemaking state can be classified as State-3 (Eq 11).

thumbnail
Fig 3. Bursting pacemaking behaviour.

(A-F) Membrane potential (V), intracellular Na+ concentration ([Na+]i), intracellular Ca2+ concentration ([Ca2+]i), fast sodium channel current (INa), Na+/K+ pumping current (INaK) and L-type calcium channel current (ICaL) with the current densities of (IK1, If) at (0.297 pA/pF, -2.52 pA/pF) (‘CASE 2’) during the entire simulating period of 800 s. (G) Expanded plots of (A-F) for the time course of pacemaking resumption (383–385 s). H: Maximum diastolic potential of automatic pacemaking activity when If is -2.52 and -1.89 pA/pF (‘CASE 2’ vs. ‘CASE 1’, solid and dotted line respectively).

https://doi.org/10.1371/journal.pcbi.1008177.g003

In ‘CASE 2’, the spontaneous oscillation was unstable, characterized by self-termination and then resumption after a quiescent period (Fig 3A). During the first pacemaking stage (simulation period from 0 to 236 s in Fig 3), the self-termination was accompanied by the overload of [Na+]i, the accumulation of [Ca2+]i, which caused the reduction of INa, the increase of INaK and the decrease of ICaL (Fig 3B–3F). An increased [Na+]i, accumulated [Ca2+]i, reduced INa, increased INaK and decreased ICaL can also be observed in the pacemaking stage in Fig 2. This suggested that the underlying mechanisms responsible for the self-termination of the pacemaking APs were similar to those of ‘CASE 1’.

It is of interest to analyse the mechanism(s) for the resumption of the pacemaking APs after a long pause. It was shown that, during the time course of the quiescent interval (236–384 s in Fig 3A–3F), the intracellular Na+ (Fig 3B) continued to be extruded out of the cell by INaK (Fig 3E). As such, the [Na+]i (Fig 3B) gradually decreased over time. The decrease in [Na+]i led to a gradually reduced INaK over the time course of quiescence (Fig 3E), which decreased the suppressive effect of INaK on depolarization. Via INaCa (S3B Fig), the intracellular Ca2+ was kept to be extruded out of the cell, leading to a decreased [Ca2+]i (Fig 3C). The reduction in [Ca2+]i reduced the Ca-induced inactivation gate of ICaL, resulting in an increased ICaL. Ca2+ concentration in the sarcoplasmic reticulum ([Ca2+]SR) also decreased via a leakage Ca release (Ileak) from SR to cytoplasm (S8C–S8D Fig) because of the reduced [Ca2+]i. Moreover, as compared with ‘CASE 1’, the increase in If helped to produce a more depolarized MDP (Fig 3H), allowing the membrane potential more easily to reach the take-off potential for initiation of the upstroke. During the quiescent stage, ICaL and INa kept at a small magnitude (Fig 3D and 3F) because of the quiescent membrane potential at which little ICaL and INa were activated. Until the Ca2+ oscillation produced a full course of action potential with a sufficiently depolarised MDP, If and INa was fully activated, facilitating the resumption of the spontaneous pacemaking activity at 385 s (Fig 3G). This process of self-termination and resumption repeated alternately, which constituted bursting behaviour.

Persistent pacemaking activity

A further increase in If ((IK1, If) at (0.297 pA/pF, -3.15 pA/pF)) produced a series of persistent spontaneous APs. Results are shown in Fig 4 (grey lines) for APs (Fig 4A), together with a phase portrait of membrane potential (V) and total membrane channel current (Itotal) (Fig 4B), IK1 (Fig 4C), and ICaL (Fig 4D). Although the spontaneous APs were sustained during the entire simulation period of 800 s, there were some incomplete depolarizations observed periodically (Fig 4A, grey line) which can be classified as State-4 according to Eq 12. This pacemaking situation was termed as ‘CASE 3’.

thumbnail
Fig 4. Persistent pacemaking activity.

The current densities of (IK1, If) of stable pacemaking activity and periodically incomplete pacemaking activity are at (0.248 pA/pF, -3.15 pA/pF) (‘CASE 4’, black lines) and (0.297 pA/pF, -3.15 pA/pF) (‘CASE 3’, grey lines) respectively. (A-D) The membrane potential (V), phase portraits of membrane potential against the total membrane channel current (Itotal), inward rectifier potassium channel current (IK1) and L-type calcium channel current (ICaL) during the simulating time course of 760–763 s. (Inset) Expanded plot during V from -75 to -45 mV and Itotal from -0.1 to 0 pA/pF marked by the asterisk in (B).

https://doi.org/10.1371/journal.pcbi.1008177.g004

When the density of IK1 was further reduced to 0.248 pA/pF (Fig 4C, black line), a stable pacemaking activity was established (Fig 4A, black line), with an average CL of 895 ms and MDP of -72.63 mV. This kind of pacemaking state can be described as State-5 by Eq 13. In this condition, the pacemaking activity was robust and the pacing CL was close to that of the native human SAN cells (approximately 800–1000 ms [55]). We termed stable pacemaking activity with (IK1, If) at (0.248 pA/pF, -3.15 pA/pF) as ‘CASE 4’.

In order to understand potential mechanism(s) underlying the genesis of incomplete pacemaking potentials in CASE 3, phase portraits of membrane potential against Itotal for incomplete (grey line) and complete (black line) depolarization APs were plotted and superimposed for comparison, as shown in Fig 4B, with a highlight of phase portraits during the diastolic pacemaking potential range from -75 mV to about -45 mV being shown in the inset. In the case of incomplete depolarization (CASE 3), there was a greater IK1 (Fig 4C) that counteracted the inward depolarizing current, leading to a smaller Itotal during the diastolic depolarization phase (see the grey line in Fig 4B and the inset). Consequentially the membrane potential failed to reach the take-off potential for the activation of ICaL (Fig 4D, grey line), leading to an incomplete course of action potential (Fig 4A, grey line). In CASE 4, with a reduced IK1 (Fig 4C, black line), there was a greater Itotal during the diastolic depolarization phase (Fig 4B and the inset, black line), which drove the membrane potential to reach the take-off potential for the activation of ICaL (Fig 4D, black line), leading to the upstroke of the action potential.

The frequency for the appearance of the incomplete AP was dependent on the density of IK1. Incomplete depolarization occurred less frequently, with progressively smaller IK1. By way of illustration, the incomplete depolarization appeared once every three cycles with the IK1 density at 0.297 pA/pF in CASE 3 (S5A Fig), but this became once every five cycles when IK1 density was reduced to 0. 277 pA/pF IK1 (S5B Fig). This suggested that a large residual of IK1 in the VM model might result in the failure of complete depolarization.

Pacemaking cycle length in IK1/If parameter space

A systematic analysis of the relationship between the calculated CL in the IK1 and If density parameter space is presented in Fig 5. In the figure, the measured CL was coloured from 650 ms in dark red to 1000 ms in yellow. In this study, we regarded persistent pacemaking action potential with CL 1000 ms or less as ‘valid pacemaking activity’ (corresponding to ‘State-5’ with CL < = 1000 ms in Fig 1), therefore, only the CLs of the valid pacemaking potentials are shown in Fig 5.

thumbnail
Fig 5. Measured cycle length in IK1/If parameter space.

The density of IK1 is from 0 to 0.396 pA/pF and the density of If is from 0 to -6.3 pA/pF at -80 mV. The measured cycle length (CL) is coloured from 650 ms in dark red to 1000 ms in yellow. White means that there is no definitely measured pacemaking CL (i.e., the pacemaking action potential is not persistent or stable) or the pacemaking activity is ‘invalid’ (CL > 1000 ms).

https://doi.org/10.1371/journal.pcbi.1008177.g005

It was shown that a sufficient depression in IK1 (up to 75%; IK1 density < 0.248 pA/pF) was required to produce a stable pacemaking action potential with a ‘valid’ pacemaking frequency. With the increase of the IK1 inhibition level, the CL became shortened at all If densities considered. Also, the more that IK1 was inhibited, the less If was needed to provoke ‘valid’ spontaneous pacemaking activity. By contrast, the effect of If on the CL presented two phases, which was dependent on the IK1 density. When IK1 was less than 0.198 pA/pF, the pacemaking ability became robust with the increase in If density. However, when IK1 was increased from 0.198 to 0.248 pA/pF, an increase in If actually slowed the pacemaking activity, leading to an increased CL.

Reciprocal role of If and IK1 in generating pacemaking APs

Further analysis was conducted to investigate the reciprocal role of reduced IK1 and increased If in generating pacemaking APs. This section analysed the role of If and IK1 in the parameter space which produced stable pacemaking activity (the ‘State-5’ in Fig 1) with the density of IK1 at 0.05 and 0.198 pA/pF. By sufficiently reducing IK1 to a density of 0.05 pA/pF alone (in the absence of If), the model was able to generate stable spontaneous APs with a CL of 1011 ms (S6A and S6E Fig, dotted lines). In this case, the incorporation of If with a small density helped to boost the pacemaking activity and increase the pacemaking frequency. It was shown that with the incorporation of If at a density of -0.63 pA/pF, the CL was reduced by 233 ms, changing from 1011 ms to 778 ms (S6A Fig). Compared with the case of If absence, incorporation of If—even with a small density—helped to depolarize cell membrane potential during the early DI phase (S6A and S6C Fig). Moreover, a similar phenomenon to Fig 2 was that the incorporation of If led to an accumulation of [Na+]i (S6B Fig) and [Ca2+]i (S6D Fig and Inset C). The accumulation of [Ca2+]i increased INaCa (S6F Fig) which contributed to the depolarization of membrane potential. As a result, the incorporation of If facilitated genesis of spontaneous APs and shortened the DI significantly thus decreased the CL.

With a fixed IK1 density of 0.05 pA/pF, the relationship between the computed CL of pacemaking APs and If density was shown in Fig 6A. In a range from 0 to -2.52 pA/pF, an increase in If density produced a marked decrease in the CL (Fig 6A), which was associated with an increase in the rate of membrane depolarization during the DI (diastolic depolarizing rate) (S2B Fig). In this range, an increase in If caused an accumulation of [Na+]i (Fig 6C), which enhanced INaCa (Fig 6D). Particularly, there was a precipitous decline of INa when If was in the range from 0 to -1.26 pA/pF (Fig 6F). This was because the augmented If elevated the MDP of the action potential (Fig 6B), which affected the activation level of INa. Furthermore, when If density was over -2.52 pA/pF, there was a less dramatic decrease in CL with an increase of If (Fig 6A). This was attributable to a reduced INa (Fig 6F) as a consequence of the gradual elevation of the MDP (Fig 6B). Another factor was that the maximum density of If was not increased linearly (Fig 6E) because of elevated MDP.

thumbnail
Fig 6. Effect of If density on the pacemaking cycle length under different IK1 density.

(A) Change of cycle length with the increase of If from 0 to -6.3 pA/pF when IK1 density is 0.05 (solid line) and 0.198 pA/pF (dotted line). (B-F) Change of maximum diastolic potential (MDP), maximum intracellular Na+ concentration ([Na+]i), maximum Na+/Ca2+ exchange current (INaCa), maximum funny current (If) and maximum fast sodium current (INa) during a pacemaking period with the increase of If from 0 to -6.3 pA/pF. (G-H) Change of the normalized total integral of main inward currents (Integral Iin) and normalized total integral of main outward currents (Integral Iout) during DI phase with the increase of If when IK1 density is 0.05 (solid line) and 0.198 pA/pF (dotted line). The inward currents include INa, INaCa and If; the outward currents include inward rectifier potassium channel current (IK1), Na+/K+ pumping current (INaK), rapid delayed rectifier potassium channel current (IKr) and slow delayed rectifier potassium channel current (IKs).

https://doi.org/10.1371/journal.pcbi.1008177.g006

Depending on the IK1 density, the relationship between CL and If density could also be bi-phasic. With a small IK1 density (0.05 pA/pF), the measured CL decreased monotonically with the increase in If density (Fig 6A, solid line). However, with a large IK1 (0.198 pA/pF), the measured CL first decreased with an increased If density, but then increased with it when If density was greater than -3.15 pA/pF, implicating a slowdown in the pacemaking activity with the increase of If (Fig 6A, dotted line). The action potentials with the current densities of (IK1, If) at (0.198 pA/pF, -3.78 pA/pF) and (0.198 pA/pF, -5.04 pA/pF) indicated that such a slowdown of pacemaking APs with an increased If was mainly due to the prolonged DI (S1 Text). The extra If accelerated pacemaking activity, leaving insufficient time for intracellular Ca2+ to be extruded, which resulted in a higher amplitude of [Ca2+]i (Fig A in S1 Text). As a consequence, INaCa amplitude increased, leading to an increased [Na+]i, and finally an increased outward INaK (Fig B in S1 Text). At the same time, If elevated the MDP (Table A in S1 Text), so the amplitude of INa decreased (Fig B in S1 Text). The changes in these currents caused a prolonged CL at a great If density. This indicated that the bi-phasic effect of If may be attributable to the delicate balance between inward currents and outward currents during the DI phase. To extend this hypothesis to the whole If parameter space, Iin and Iout were defined as the total integral of three dominant inward currents during the DI phase (INa, INaCa and If) (Eq 15) and the total integral of four dominant outward currents during the DI phase (IK1, INaK, IKr and IKs) (Eq 16). At a low IK1 density of 0.05 pA/pF, with the increase in If density, there was a monotonic decrease of CL (Fig 6A, solid line). However, at a large IK1 density (e.g., 0.198 pA/pF), more than -3.15 pA/pF If resulted in an increased CL (Fig 6A, dotted line). This observation can be explained by the unsaturated Iin. The density of Iin was an integrated consequence of MDP, the activation degree of INa and If, as well as the density of INaCa. At 0.05 pA/pF IK1 density, Iout was small, therefore INa, INaCa and If was saturated (i.e., Iin was saturated). However, when IK1 was large, increased Iout led to a more negative MDP which resulted in an increased Iin due to more activated INa, INaCa and If. But Iin reached at a asymptotic value after If density was greater than -3.15 pA/pF (Fig 6G, dotted line) because the a similar level of the diastolic [Ca2+]i (i.e., minimum [Ca2+]i) at different IK1 caused a decreased normalized integral of INaCa (Fig C in S1 Text), therefore Iin was not saturated at large IK1 (Fig 6G, dotted line). Consequentially, the Iout outbalanced the Iin, leading to a prolonged DI that increased the CL at large IK1.

Incorporation of ICaT in IK1/If pacemaker model

The incorporation of ICaT in the IK1/If pacemaker model with the current densities of (IK1, If) at (0.297 pA/pF, -0.63 pA/pF) induced automaticity in non-pacemaking cell model (S7A Fig). It was shown that ICaT initiated the oscillation of Ca2+ in the cytoplasm and the SR (S7B and S7C Fig) in the non-pacemaking cell model, activating the INaCa and ICaL (S7D and S7E Fig).

However, when ICaT was incorporated into a stable IK1/If pacemaker model with the current densities of (IK1, If) at (0.099 pA/pF, -0.63 pA/pF), an increased pacemaking CL was observed (853 ms vs. 950 ms, S8A Fig). The reason was that the addition of ICaT in the model affected the Ca2+ dynamics, resulting in an accumulation of [Ca2+]i as well as [Ca2+]SR, leading to an increased INaCa and greater inactivation of ICaL (S8C–S8F Fig). An increased INaCa consequently caused an accumulation of [Na+]i, leading to an increased outward INaK (S8G Fig). More importantly, an increased INaCa elevated the MDP, leading to a less activated INa and If (S8H and S8I Fig). These together with an increased INaK produced a prolonged CL.

Discussion

Summary of major findings

Biological experiments provided possibilities to transform non-pacemaking CMs or stem cells into bio-pacemaker cells by regulating the expression of If [13,28,29,36,37] or IK1 [11,20,21]. Computationally, bifurcation theory was used to analyse the effect of the density of an individual ion channel current on the membrane potential of a cardiac cell [47,50], by which decisive currents in pacemaking initiation can be screened out. The interaction between multiple ion channels in cardiac pacemaking has also been considered in some prior studies. Lakatta et al. [51] investigated the effect of multiple component ion channels on cardiac pacemaking by identifying numerically minimal ensembles of ion channels in the SAN model. Their study provided a simplification of the model which may be suitable for further bifurcation analysis. However, due to the simplification, the model does not reflect the whole ionic dynamics of cardiac cells. In another study, Kurata et al. [50] simulated the combined action of If and ICaT, Ist or ICaL with three specific values of ICaT, Ist or ICaL considered. That study also suggested that there was a threshold of IK1 below which automaticity can be induced in If-incorporated ventricular model, but potential underlying ionic mechanisms on how balanced IK1/If modulates the stability of the pacemaking activity was not shown. Considering the biological possibility that the superiority of combined action of IK1 and If [10,32,44] and unclear interaction between IK1 and If in the initiation of stable pacemaking activity in a whole cardiac cell model, the present study developed a virtual bio-engineered pacemaking cell model based on a human ventricular model by downregulating of IK1 and incorporating If. In comparison with previous computational modelling studies on bio-pacemakers [50,51], the present study provides new insights into understandings of 1) the dynamic regulation of ionic concentrations and ionic channel currents in IK1/If-induced ventricular pacemaker; 2) the interaction between IK1 and If in the genesis of pacemaking action potentials; and 3) the stability of pacemaking potentials in wide IK1/If parameter space.

The present IK1/If pacemaker model can initiate robust and stable pacemaking activity by balancing the actions of reduced IK1 and increased If, though the effect of each manipulation on pacemaking activity is different. While the action of a reduced IK1 on the pacemaking activity is mono-phasic, that of an increased If is biphasic. It was shown that inhibiting IK1 promotes pacemaking ability and stability. The incorporation of If at an appropriate level promotes pacemaking activity, but an excessive If might result in abnormal pacemaking activity accompanied by abnormal intracellular ionic concentrations (such as pacemaking activity with periodically incomplete depolarization) or weak pacemaking ability, which could be proarrhythmic. As a result, the reciprocal interaction between IK1 and If is crucial for producing stable spontaneous pacemaking activity in VMs. In the present model, specific If density at different IK1 densities or vice versa was suggested.

This study demonstrated the feasibility of creating VM-based pacemaker cells by downregulating IK1 and upregulating If and provided evidence of the superiority of IK1/If-based pacemaker model theoretically. The results of this study may be useful for optimizing the future design of engineered bio-pacemakers.

Role of IK1 suppression on pacemaking activity

Simulation results that suppressing IK1 by 75% - 100% can initiate stable pacemaking behaviour are in consistence with those of experimental findings, where it has been found that more than 80% inhibition of IK1 was required to produce a pacemaking phenomenon in guinea-pig’s ventricular cavity [11,21]. It is also in agreement with previous bifurcation analyses in showing that it required IK1 to be reduced to at least 15% of the control value to transform a VM cell model to be auto-rhythmic [47]. And a complete block of IK1 produced a spontaneous pacemaking activity with a CL of 795 ms [47], close to 833 ms when IK1 was completely suppressed in the present study. The effect of IK1 suppression on pacemaking activity was monotonic in our pacemaker model. The more the IK1 is blocked, the faster the pacemaking activity is with all If densities considered. Similar results have also been observed in another human ventricular cell model [56] based on modifications of the O’Hara and Rudy model (ORD model) [57] (Fig A in S2 Text, solid and dotted lines).

Though our simulation results suggest an important role of sufficient suppression of IK1 in generating persistent and stable pacemaking APs, it is noteworthy that the deficiency of IK1 has been reported to be lethal for adult rodents [58]; and loss function of Kir2 gene may prolong QT intervals as well as cause Andersen’s syndrome [59]. Consequently, suppression of IK1 from VM for generating a biological pacemaker may only be suitable when applied to highly localized, designated ‘pacemaker’ regions.

Role of If on pacemaking activity

If has been shown to play an important role in generating pacemaking APs in both native [13,22,28,29,36,37] and engineered pacemakers [43]. Experimentally it has been shown that high expression of HCN2 can initiate spontaneous beats in neonatal rat VMs [22,36] and improve spontaneous beats in rabbit CMs [13]. HCN4 incorporation by the expression of TBX18 can also initiate spontaneous pacemaking activity in both rodent VMs [10] and porcine VMs [12].

In the present study, If helped to promote pacemaking activity, via its action of depolarization during the diastolic depolarization phase as well as its action on the intracellular ion concentrations. The inclusion of If in the VM cell model caused the accumulation of [Na+]i by Na+ channel of If [53]. The enhanced pacemaking activity caused by extra If also induced the accumulation [Ca2+]i because there was not enough time to extrude Ca2+ from the cytoplasm [60]. The accumulated [Ca2+]i increased INaCa, which promoted membrane potential depolarization especially during the early stage of DI (S6 Fig). Such a promoting action of If in bio-pacemaking can also be seen in another independent model as shown in S2 Text.

The increase in If density can enhance the automaticity in most cases. However, the effect of If on the pacemaking activity was observed to be bi-phasic. When it was increased to be over a threshold, excessive If resulted in an elevated MDP (Fig 6), which caused a reduced activation of If and INa, leading to a slowdown of the ability of pacemaking activity. This phenomenon occurred when the IK1 was not suppressed sufficiently. The impairing effect of excessive If on pacemaking APs was also observed in another ventricular pacemaker model based on modification of the ORD model [56] (S2 Text). It was shown that a greater increase in If density even terminated pacemaking activity (Fig B in S2 Text). The possible impairing effect of If on INa was verified by the fact that in the bio-pacemaker induced by HCN2 expression [61], co-expression of the skeletal muscle sodium channel 1 (SkM1), in order to hyperpolarize the action potential threshold, helped to counterbalance the negative effect of If overexpression, producing an accelerated depolarization phase. In fact, in the original TP06 model, the peak amplitude of INa was about -300 pA/pF at the resting potential of -86.2 mV [54]. In our pacemaker model, the peak amplitude of INa was significantly reduced because of the elevated MDP. This suggested that to counterbalance the elevated MPD and the reduced INa, an increase in the channel expression of INa may help to produce an enhanced pacemaker. This might be simulated by increasing INa conductance in the model study. Furthermore, when IK1 was large, an increase in If even lengthened pacemaking period or caused unstable pacemaking behaviour (Fig 1). This simulation result is in agreement with a previous biological experimental study that observed arrhythmicity when acute HCN gene was expressed [42]. Another experimental study showed that HCN2-expression caused an excessive increase in the basal beating rate [62]. In our model, it has been also observed that excessive If may cause an overly fast pacemaking rate.

Reciprocal interaction between IK1 and If

Our study demonstrates that the reciprocal interaction between IK1 and If plays a crucial role in creating stable and persistent pacemaking. Only an optimal combination of IK1 and If can initiate stable pacemaking activity. In the present pacemaker model, the greater the degree of IK1 suppression, the smaller was the If density required for the generation of spontaneous oscillation (Fig 1). And modulation of the two currents simultaneously helps to create a physiologically-like pacemaker that is better than that produced by manipulating IK1 or If alone (Fig 5). Such observation of reciprocal interaction between IK1 and If in pacemaking is consistent with previous experimental observations. Previous studies have shown that although suppressing IK1 [11,21], or incorporating sufficient If [22] alone was able to initiate pacemaking activity in VM cells, a pacemaker constructed by TBX18 showed greater stability, due to its combined actions of IK1 reduction and If increase [10]. Another experiment in porcine VMs [12] also indicated that TBX18 expression did not increase the risk of arrhythmia, which means that a mixed-current approach is probably a superior means of producing a bio-pacemaker. Experiments in a Kir2.1/HCN2 HEK293 cell [45] and Kir2.1/HCN4 [43] showed that IK1 may actually recruit more If by activating current at more negative membrane voltages because IK1 was the only hyperpolarizing current in these experiments. Our simulations, however, did not yield such a result because the interaction of other outward currents (such as INaK, IKr and IKs) contributed to the hyperpolarization of membrane potential and helped the activation of If. We thought an integrated action between all of ionic currents in cardiac cells should be considered, rather than evaluated specific ionic currents in a partial model.

In addition, simulation results indicated that IK1 expression level may influence the If’s effect on the pacemaking activity (Fig 6A). Excessive IK1 hindered If’s ability to modulate pacemaking activity. This further showed that the balanced expression of IK1 and If affected the balance between the inward and outward currents during the diastolic depolarization phase, thus affected the membrane potential state and the pacemaking CL of the pacemaker. An experiment showed a coincident result that the expression of HCN2 in adult rat VMs could not cause spontaneous beats due to the high expression of IK1 [22], but in neonatal rats, the IK1 was less so that expressing HCN2 could provoke automaticity. Similarly, such a dynamic balance between the inward and outward currents during the repolarization and the diastolic depolarization phase was also affected by other repolarization currents, such as IKr, IKs and INaK etc. Possible effects of modulating these repolarization currents on the bio-pacemaking warrants further studies in the future.

The present IK1/If-induced pacemaker model exhibited greater robustness than IK1-based or If-based pacemaker models. In the IK1-based model, the range of IK1 density that could initiate spontaneous beatings was from 0 to 0.0246 pA/pF, while in IK1/If-based pacemaker model, this value extended to 0.248 pA/pF (Fig 1). The superiority of IK1/If-based pacemaker model than If-based pacemaker model seemed to be more distinct. Incorporating If alone at a high density of -6.3 pA/pF could not provoke any spontaneous beating, but combining with the suppression of IK1, small incorporation of If helped to ignite automaticity (Fig 1). The flexibility of this system also reflected in the easy modulation of CL via manipulating IK1 and If density (Fig 5).

Compared with the human SAN cell model developed by Fabbri et al. [53] and human SAN cell [64], the action potential generated by the IK1/If-induced pacemaker model had a longer action potential duration at 90% (APD90) and a more negative MDP when the CL was similar (see Table 2). Such differences may be attributable to the fact that there are regional differences in the functional expression of ionic currents between the SAN and ventricular myocytes [63]. In the presented IK1/If-induced pacemaker model, though we have reduced IK1 and incorporated If to a similar level of ion channel current densities as the SAN, other ionic currents in the present IK1/If-induced pacemaker model inherited the same channel properties of VMs cell model, causing different pacemaker behaviour in the IK1/If biological pacemaker model as compared to the SAN model.

thumbnail
Table 2. Comparison of pacemaker behaviours between the SAN cell and the bio-pacemaker cell.

https://doi.org/10.1371/journal.pcbi.1008177.t002

Ca2+ dynamics in IK1/If pacemaker model

There is still debate about the relative role of two pacemaking mechanisms of membrane clock (If) and Ca2+ clock [65]. A biological experiment demonstrated that Ca2+-stimulated adenylyl cyclase AC1 can promote pacemaking ability in HCN2-expressed left bundle branches [62]. A model study [66] that evaluated the synergism between Ca2+ clock and membrane clock in SAN central cell, also showed that the synergistic system was more robust and flexible. Another study [67] showed that VMs may also have Ca2+ clock, which provided a probability for the creation of Ca2+ clock-based bio-pacemaker. The role of Ca2+ dynamics in bio-pacemaker was also shown in our IK1/If pacemaker model. As shown in Fig 3G, the resumption of pacemaking activity in bursting behaviour was provoked by the oscillation of [Ca2+]i. This indicated that the Ca2+ dynamics played an important role in the creation of bio-pacemaker, which warrants further study.

Furthermore, considering the role of ICaT in the genesis of pacemaking APs in native SAN cells, a theoretical investigation of potential role(s) of ICaT in the bio-pacemaker was conducted using the IK1/If-modulated pacemaker model. It was shown the effect of ICaT had dual aspects. On one hand, the incorporation of ICaT might promote the pacemaking ability of ventricular pacemaker [50]. by initiating Ca2+ oscillation thus producing spontaneous beatings in quiet pacemaker model. On the other hand, the incorporation of ICaT might affect the MDP, leading to secondary actions on the homeostasis of ion concentrations, as well as ion channel currents including INa, If, INaCa and INaK, which slowed down the pacemaking activity.

Limitations

Limitations of the human VMs model we used in this study has been described elsewhere [54]. In this study, the If formulation of human SAN [53] was incorporated into the original VMs model. The properties of If, including the conductance of If, the half-maximal activation voltage (V1/2) and time constants of the activation, may present species-dependence. In the present version, we only consider the conductance of If but have not discussed other properties of If. Moreover, in this study, we only investigated the pacemaking action potential at the single-cell level, without considering the intercellular electrical coupling between pacemaker cells as presented in the SAN tissue. These limitations are now being addressed for future versions of the model. In addition, bio-pacemaker models developed from other cardiac cell types, such as atrial myocytes, warrant future studies. Additionally, the other pacemaking-related currents in native SAN cells, such as INa and Ist, could also be adjusted for creating stable bio-pacemaker.

One of possible advantages of bio-pacemaker over the traditional electronic pacemaker is at its possible sensitivity to autonomic regulation. It is of interest to study how the pacemaking action potentials are modulated by autonomic regulation by β-Adrenergic receptor stimulation or cholinergic receptor stimulation [10], which warrants further future investigation.

It is necessary to highlight these limitations, they nevertheless do not affect our conclusions on the underlying pacemaking mechanisms of engineered bio-pacemaker cells, especially regarding the reciprocal interaction of IK1 and If for a robust bio-pacemaker in modified VMs.

Supporting information

S1 Fig. I-V relation of IK1 and If with different expression level.

SK1 and Sf are defined as scaling factors used to simulate the change of IK1 and If expression level. (A) The I-V curve of IK1 with SK1 of 1, 0.4, 0.1 that gives IK1 densities in the I-V curve at -80 mV 0.99, 0.396 and 0.099 pA/pF respectively. (B) The I-V curve of If with Sf of 1, 5, 10 that gives If densities in the I-V curve at -80 mV -0.63, -3.15 and -6.3 pA/pF respectively.

https://doi.org/10.1371/journal.pcbi.1008177.s001

(TIF)

S2 Fig. Change of diastolic depolarizing rate with the increase of If density.

(A) Definition of diastolic depolarizing rate. MDP: maximum diastolic potential; t1: the time when membrane potential is MDP; t2: the time when potential arrives -55 mV (i.e., around the activation potential of the ICaL). (B) Change of diastolic depolarizing rate with the increase of If density from 0 to -6.3 pA/pF when IK1 density at -80 mV is at 0.05 pA/pF.

https://doi.org/10.1371/journal.pcbi.1008177.s002

(TIF)

S3 Fig. Ca dynamic of the transient and bursting pacemaking behaviour.

(A) Na+/Ca2+ exchange current (INaCa) during the entire simulating period of 800 s with the current densities of (IK1, If) at (0.297pA/pF, -1.89 pA/pF). (B-D) Na+/Ca2+ exchange current (INaCa), Ca2+ concentration in sarcoplasmic reticulum ([Ca2+]SR) and leakage current from SR to cytoplasm (Ileak) during the entire simulating period of 800 s with the current densities of (IK1, If) at (0.297 pA/pF, -2.52 pA/pF).

https://doi.org/10.1371/journal.pcbi.1008177.s003

(TIF)

S4 Fig. Transient spontaneous pacemaking behaviour.

Membrane potential (V) during the entire simulation period of 400 s with the current densities of (IK1, If) at (0.178 pA/pF, -0.63 pA/pF).

https://doi.org/10.1371/journal.pcbi.1008177.s004

(TIF)

S5 Fig. Persistent pacemaking activity with periodically incomplete depolarization at different densities of IK1.

(A-B) Membrane potential (V) with the current densities of (IK1, If) at (0.297 pA/pF, -3.15 pA/pF) and (0.277 pA/pF, -3.15 pA/pF) during simulating time course of 360–370 s.

https://doi.org/10.1371/journal.pcbi.1008177.s005

(TIF)

S6 Fig. Positive effect of If on pacemaking ability.

(A-F) The membrane potential (V), intracellular Na+ concentration ([Na+]i), “funny” current (If), intracellular Ca2+ concentration ([Ca2+]i), inward rectifier potassium channel current (IK1) and Na+/Ca2+ exchange current (INaCa) during simulating time course of 400–403 s when the current densities of (IK1, If) are at (0.05 pA/pF, 0 pA/pF) and (0.05 pA/pF, -0.63 pA/pF) (dotted and solid line respectively). (Inset A-B) Expanded plots of [Na+]i traces for the time course marked by the horizontal brackets with asterisks in (B). (Inset C) The change of [Ca2+]i with simulating time course of 0–100 s.

https://doi.org/10.1371/journal.pcbi.1008177.s006

(TIF)

S7 Fig. Positive effect of incorporating ICaL on quiet IK1/If pacemaker model.

(A-F) Membrane potential (V), intracellular Ca2+ concentration ([Ca2+]i), Ca2+ concentration in sarcoplasmic reticulum ([Ca2+]SR), Na+/Ca2+ exchange current (INaCa), L-type calcium channel current (ICaL) and T-type calcium channel current (ICaT) with the current densities of (IK1, If) at (0.297 pA/pF, -0.63 pA/pF) during the simulating period of 0–20 s.

https://doi.org/10.1371/journal.pcbi.1008177.s007

(TIF)

S8 Fig. Side effect of incorporating ICaL on stable IK1/If pacemaker model.

(A) Membrane potential (V) during the simulating period of 300–302 s. (B-H) Membrane potential (V), intracellular Ca2+ concentration ([Ca2+]i), Ca2+ concentration in sarcoplasmic reticulum ([Ca2+]SR), Na+/Ca2+ exchange current (INaCa), L-type calcium channel current (ICaL), Na+/K+ pumping current (INaK), fast sodium current (INa) and “funny” current (If) with the current densities of (IK1, If) at (0.099 pA/pF, -0.63 pA/pF) during the simulating period of 0–20 s.

https://doi.org/10.1371/journal.pcbi.1008177.s008

(TIF)

S1 Text. Prolonged cycle length at greater If density.

https://doi.org/10.1371/journal.pcbi.1008177.s009

(DOC)

References

  1. 1. Cohen IS, Brink PR, Robinson RB, Rosen MR. The why, what, how and when of biological pacemakers. Nat Clin Pract Card. 2005;2(8):374–5. pmid:16119693
  2. 2. Rosen MR. Gene Therapy and Biological Pacing. New Engl J Med. 2014;371(12):1158–9. pmid:25229921
  3. 3. Rosen MR, Brink PR, Cohen IS, Robinson RB. Cardiac pacing: from biological to electronic… to biological? Circ Arrhythm Electrophysiol. 2008;1(1):54–61. pmid:19808394
  4. 4. Rosen MR, Robinson RB, Brink PR, Cohen IS. The road to biological pacing. Nature reviews Cardiology. 2011;8(11):656–66. pmid:21844918
  5. 5. Wilders R, Verheijck EE, Kumar R, Goolsby WN, van Ginneken AC, Joyner RW, et al. Model clamp and its application to synchronization of rabbit sinoatrial node cells. Am J Physiol. 1996;271(5 Pt 2):H2168–82. pmid:8945938
  6. 6. Kapoor N, Galang G, Marban E, Cho HC. Transcriptional suppression of connexin43 by TBX18 undermines cell-cell electrical coupling in postnatal cardiomyocytes. J Biol Chem. 2011;286(16):14073–9. pmid:21205823
  7. 7. Freudenberger RS, Wilson AC, Lawrence-Nelson J, Hare JM, Kostis JB. Permanent pacing is a risk factor for the development of heart failure. American Journal of Cardiology. 2005;95(5):671–4. pmid:15721119
  8. 8. Cingolani E, Goldhaber JI, Marban E. Next-generation pacemakers: from small devices to biological pacemakers. Nature reviews Cardiology. 2018;15(3):139–50. pmid:29143810
  9. 9. Shlapakova IN, Nearing BD, Lau DH, Boink GJJ, Danilo P, Kryukova Y, et al. Biological pacemakers in canines exhibit positive chronotropic response to emotional arousal. Heart Rhythm. 2010;7(12):1835–40. pmid:20708103
  10. 10. Kapoor N, Liang WB, Marban E, Cho HC. Direct conversion of quiescent cardiomyocytes to pacemaker cells by expression of Tbx18. Nat Biotechnol. 2013;31(1):54–+. pmid:23242162
  11. 11. Miake J, Marban E, Nuss HB. Functional role of inward rectifier current in heart probed by Kir2.1 overexpression and dominant-negative suppression. J Clin Invest. 2003;111(10):1529–36. pmid:12750402
  12. 12. Hu YF, Dawkins JF, Cho HC, Marban E, Cingolani E. Biological pacemaker created by minimally invasive somatic reprogramming in pigs with complete heart block. Sci Transl Med. 2014;6(245). pmid:25031269
  13. 13. Zhou YF, Yang XJ, Li HX, Han LH, Jiang WP. Mesenchymal stem cells transfected with HCN2 genes by LentiV can be modified to be cardiac pacemaker cells. Med Hypotheses. 2007;69(5):1093–7. pmid:17449188
  14. 14. Gorabi AM, Hajighasemi S, Tafti HA, Atashi A, Soleimani M, Aghdami N, et al. TBX18 transcription factor overexpression in human-induced pluripotent stem cells increases their differentiation into pacemaker-like cells. Journal of cellular physiology. 2019;234(2):1534–46. pmid:30078203
  15. 15. Noble D. The surprising heart: a review of recent progress in cardiac electrophysiology. The Journal of physiology. 1984;353:1–50. pmid:6090637
  16. 16. DiFrancesco D. The contribution of the ’pacemaker’ current (if) to generation of spontaneous activity in rabbit sino-atrial node myocytes. The Journal of physiology. 1991;434:23–40. pmid:2023118
  17. 17. DiFrancesco D. The role of the funny current in pacemaker activity. Circ Res. 2010;106(3):434–46. pmid:20167941
  18. 18. Mesirca P, Torrente AG, Mangoni ME. T-type channels in the sino-atrial and atrioventricular pacemaker mechanism. Pflugers Arch. 2014;466(4):791–9. pmid:24573175
  19. 19. Guo J, Ono K, Noma A. A sustained inward current activated at the diastolic potential range in rabbit sino-atrial node cells. The Journal of physiology. 1995;483 (Pt 1):1–13. pmid:7776225
  20. 20. Zaritsky JJ, Redell JB, Tempel BL, Schwarz TL. The consequences of disrupting cardiac inwardly rectifying K+ current (I-K1) as revealed by the targeted deletion of the murine Kir2.1 and Kir2.2 genes. J Physiol-London. 2001;533(3):697–710. pmid:11410627
  21. 21. Miake J, Marban E, Nuss HB. Gene therapy—Biological pacemaker created by gene transfer. Nature. 2002;419(6903):132–3. pmid:12226654
  22. 22. Qu JH, Barbuti A, Protas L, Santoro B, Cohen IS, Robinson RB. HCN2 overexpression in newborn and adult ventricular myocytes—Distinct effects on gating and excitability. Circ Res. 2001;89(1):E8–E14. pmid:11440985
  23. 23. Qu JH, Plotnikov AN, Danilo P, Shlapakova I, Cohen IS, Robinson RB, et al. Expression and function of a biological pacemaker in canine heart. Circulation. 2003;107(8):1106–9. pmid:12615786
  24. 24. Plotnikov AN, Sosunov EA, Qu JH, Shlapakova IN, Anyukhovsky EP, Liu LL, et al. Biological pacemaker implanted in canine left bundle branch provides ventricular escape rhythms that have physiologically acceptable rates. Circulation. 2004;109(4):506–12. pmid:14734518
  25. 25. Ionta V, Liang WB, Kim EH, Rafie R, Giacomello A, Marban E, et al. SHOX2 Overexpression Favors Differentiation of Embryonic Stem Cells into Cardiac Pacemaker Cells, Improving Biological Pacing Ability. Stem Cell Rep. 2015;4(1):129–42. pmid:25533636
  26. 26. Xue T, Cho HC, Akar FG, Tsang SY, Jones SP, Marban E, et al. Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes—Insights into the development of cell-based pacemakers. Circulation. 2005;111(1):11–20. pmid:15611367
  27. 27. Kehat I, Khimovich L, Caspi O, Gepstein A, Shofti R, Arbel G, et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol. 2004;22(10):1282–9. pmid:15448703
  28. 28. Bruzauskaite I, Bironaite D, Bagdonas E, Skeberdis VA, Denkovskij J, Tamulevicius T, et al. Relevance of HCN2-expressing human mesenchymal stem cells for the generation of biological pacemakers. Stem Cell Res Ther. 2016;7. pmid:26753925
  29. 29. Zhang H, Li SC, Qu D, Li BL, He B, Wang C, et al. Autologous biological pacing function with adrenergic-responsiveness in porcine of complete heart block. Int J Cardiol. 2013;168(4):3747–51. pmid:23835270
  30. 30. Planat-Benard V, Menard C, Andre M, Puceat M, Perez A, Garcia-Verdugo JM, et al. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ Res. 2004;94(2):223–9. pmid:14656930
  31. 31. Choi YS, Dusting GJ, Stubbs S, Arunothayaraj S, Han XL, Collas P, et al. Differentiation of human adipose-derived stem cells into beating cardiomyocytes. J Cell Mol Med. 2010;14(4):878–89. pmid:20070436
  32. 32. Chen L, Deng ZJ, Zhou JS, Ji RJ, Zhang X, Zhang CS, et al. Tbx18-dependent differentiation of brown adipose tissue-derived stem cells toward cardiac pacemaker cells. Mol Cell Biochem. 2017;433(1–2):61–77. pmid:28382491
  33. 33. Chauveau S, Anyukhovsky EP, Ben-Ari M, Naor S, Jiang YP, Danilo P, et al. Induced Pluripotent Stem Cell-Derived Cardiomyocytes Provide In Vivo Biological Pacemaker Function. Circ-Arrhythmia Elec. 2017;10(5). pmid:28500172
  34. 34. Gorabi AM, Hajighasemi S, Khori V, Soleimani M, Rajaei M, Rabbani S, et al. Functional biological pacemaker generation by T-Box18 protein expression via stem cell and viral delivery approaches in a murine model of complete heart block. Pharmacological research. 2019;141:443–50. pmid:30677516
  35. 35. Kleber AG, Rudy Y. Basic mechanisms of cardiac impulse propagation and associated arrhythmias. Physiol Rev. 2004;84(2):431–88. pmid:15044680
  36. 36. Potapova I, Plotnikov A, Lu ZJ, Danilo P, Valiunas V, Qu JH, et al. Human mesenchymal stem cells as a gene delivery system to create cardiac pacemakers. Circ Res. 2004;94(7):952–9. pmid:14988226
  37. 37. Plotnikov AN, Shlapakova I, Szabolcs MJ, Danilo P, Lorell BH, Potapova IA, et al. Xenografted adult human mesenchymal stem cells provide a platform for sustained biological pacemaker function in canine heart. Circulation. 2007;116(7):706–13. pmid:17646577
  38. 38. Saito Y, Nakamura K, Yoshida M, Sugiyama H, Ohe T, Kurokawa J, et al. Enhancement of Spontaneous Activity by HCN4 Overexpression in Mouse Embryonic Stem Cell-Derived Cardiomyocytes—A Possible Biological Pacemaker. Plos One. 2015;10(9). pmid:26384234
  39. 39. Cho HC, Kashiwakura Y, Marban E. Creation of a biological pacemaker by cell fusion. Circ Res. 2007;100(8):1112–5. pmid:17395872
  40. 40. Azene EM, Xue T, Marban E, Tomaselli GF, Li RA. Non-equilibrium behaviour of HCN channels: Insights into the role of HCN channels in native and engineered pacemakers. Cardiovasc Res. 2005;67(2):263–73. pmid:16005302
  41. 41. Lieu DK, Chan YC, Lau CP, Tse HF, Siu CW, Li RA. Overexpression of HCN-encoded pacemaker current silences bioartificial pacemakers. Heart Rhythm. 2008;5(9):1310–7. pmid:18693074
  42. 42. Kuwabara Y, Kuwahara K, Takano M, Kinoshita H, Arai Y, Yasuno S, et al. Increased Expression of HCN Channels in the Ventricular Myocardium Contributes to Enhanced Arrhythmicity in Mouse Failing Hearts. J Am Heart Assoc. 2013;2(3). pmid:23709563
  43. 43. Sun Y, Timofeyev V, Dennis A, Bektik E, Wan XP, Laurita KR, et al. A Singular Role of I-K1 Promoting the Development of Cardiac Automaticity during Cardiomyocyte Differentiation by I-K1-Induced Activation of Pacemaker Current. Stem Cell Rev Rep. 2017;13(5):631–43. pmid:28623610
  44. 44. Yang M, Zhang GG, Wang T, Wang X, Tang YH, Huang H, et al. TBX18 gene induces adipose-derived stem cells to differentiate into pacemaker-like cells in the myocardial microenvironment. Int J Mol Med. 2016;38(5):1403–10. pmid:27632938
  45. 45. Chen K, Zuo D, Wang SY, Chen H. Kir2 inward rectification-controlled precise and dynamic balances between Kir2 and HCN currents initiate pacemaking activity. FASEB J. 2018;32(6):3047–57. pmid:29401592
  46. 46. Silva J, Rudy Y. Mechanism of pacemaking in I-K1-downregulated myocytes. Circ Res. 2003;92(3):261–3. pmid:12595336
  47. 47. Kurata Y, Hisatome I, Matsuda H, Shibamoto T. Dynamical mechanisms of pacemaker generation in I-K1-downregulated human ventricular myocytes: Insights from bifurcation analyses of a mathematical model. Biophys J. 2005;89(4):2865–87. pmid:16040746
  48. 48. Tong WC, Holden AV. Induced pacemaker activity in virtual mammalian ventricular cells. Lect Notes Comput Sc. 2005;3504:226–35.
  49. 49. Kurata Y, Matsuda H, Hisatome I, Shibamoto T. Roles of hyperpolarization-activated current If in sinoatrial node pacemaking: insights from bifurcation analysis of mathematical models. American journal of physiology Heart and circulatory physiology. 2010;298(6):H1748–60. pmid:20363885
  50. 50. Kurata Y, Matsuda H, Hisatome I, Shibamoto T. Effects of pacemaker currents on creation and modulation of human ventricular pacemaker: theoretical study with application to biological pacemaker engineering. American journal of physiology Heart and circulatory physiology. 2007;292(1):H701–18. pmid:16997892
  51. 51. Maltsev VA, Lakatta EG. Numerical models based on a minimal set of sarcolemmal electrogenic proteins and an intracellular Ca(2+) clock generate robust, flexible, and energy-efficient cardiac pacemaking. Journal of molecular and cellular cardiology. 2013;59:181–95. pmid:23507256
  52. 52. ten Tusscher KH, Panfilov AV. Alternans and spiral breakup in a human ventricular tissue model. American journal of physiology Heart and circulatory physiology. 2006;291(3):H1088–100. pmid:16565318
  53. 53. Fabbri A, Fantini M, Wilders R, Severi S. Computational analysis of the human sinus node action potential: model development and effects of mutations. The Journal of physiology. 2017;595(7):2365–96. pmid:28185290
  54. 54. ten Tusscher KHWJ, Noble D, Noble PJ, Panfilov AV. A model for human ventricular tissue. Am J Physiol-Heart C. 2004;286(4):H1573–H89.
  55. 55. Zhang H, Butters T, Adeniran I, Higham J, Holden AV, Boyett MR, et al. Modeling the chronotropic effect of isoprenaline on rabbit sinoatrial node. Frontiers in physiology. 2012;3:241. pmid:23060799
  56. 56. Whittaker DG, Ni H, Benson AP, Hancox JC, Zhang H. Computational Analysis of the Mode of Action of Disopyramide and Quinidine on hERG-Linked Short QT Syndrome in Human Ventricles. Frontiers in physiology. 2017;8:759. pmid:29085299
  57. 57. O’Hara T, Virag L, Varro A, Rudy Y. Simulation of the undiseased human cardiac ventricular action potential: model formulation and experimental validation. PLoS computational biology. 2011;7(5):e1002061. pmid:21637795
  58. 58. Irnich W, de Bakker JM, Bisping HJ. Electromagnetic interference in implantable pacemakers. Pacing Clin Electrophysiol. 1978;1(1):52–61. pmid:83621
  59. 59. Plaster NM, Tawil R, Tristani-Firouzi M, Canun S, Bendahhou S, Tsunoda A, et al. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen’s syndrome. Cell. 2001;105(4):511–9. pmid:11371347
  60. 60. Zhang H, Tong W-C, Garratt C, Holden A. Stability of genetically engineered cardiac pacemaker—role of intracellular CA2+ handling. Comput Cardiol2005. p. 969–72.
  61. 61. Boink GJJ, Duan L, Nearing BD, Shlapakova IN, Sosunov EA, Anyukhovsky EP, et al. HCN2/SkM1 Gene Transfer Into Canine Left Bundle Branch Induces Stable, Autonomically Responsive Biological Pacing at Physiological Heart Rates. J Am Coll Cardiol. 2013;61(11):1192–201. pmid:23395072
  62. 62. Boink GJ, Nearing BD, Shlapakova IN, Duan L, Kryukova Y, Bobkov Y, et al. Ca(2+)-stimulated adenylyl cyclase AC1 generates efficient biological pacing as single gene therapy and in combination with HCN2. Circulation. 2012;126(5):528–36. pmid:22753192
  63. 63. Ono K, Iijima T. Pathophysiological significance of T-type Ca2+ channels: properties and functional roles of T-type Ca2+ channels in cardiac pacemaking. J Pharmacol Sci. 2005;99(3):197–204. pmid:16272791
  64. 64. Verkerk AO, Wilders R, van Borren MM, Peters RJ, Broekhuis E, Lam K, et al. Pacemaker current (I(f)) in the human sinoatrial node. Eur Heart J. 2007;28(20):2472–8. pmid:17823213
  65. 65. Pan L, Lines GT, Maleckar MM, Aslak T. Mathematical models of cardiac pacemaking function. Frontiers in Physics. 2013;1.
  66. 66. Maltsev VA, Lakatta EG. Synergism of coupled subsarcolemmal Ca2+ clocks and sarcolemmal voltage clocks confers robust and flexible pacemaker function in a novel pacemaker cell model. 2009;296(3):H594–615.
  67. 67. Sirenko S, Maltsev VA, Maltseva LA, Yang D, Lukyanenko Y, Vinogradova TM, et al. Sarcoplasmic reticulum Ca2+ cycling protein phosphorylation in a physiologic Ca2+ milieu unleashes a high-power, rhythmic Ca2+ clock in ventricular myocytes: relevance to arrhythmias and bio-pacemaker design. Journal of molecular and cellular cardiology. 2014;66:106–15. pmid:24274954